Advertisement
In a CHEST expert panel report

Guidance Developed for Lung Cancer Screening During COVID-19

0
Consensus statement covers lung cancer screening and monitoring, evaluation, management of lung nodules
Just one in five pediatric cancer patients enroll in clinical trials

Fewer Children Enrolling in Pediatric Cancer Trials

0
Adolescent and young adult cancer patients underrepresented in clinical trials
Whole-body diffusion-weighted magnetic resonance imaging shows good agreement with 18 fluorodeoxyglucose positron emission tomography for assessing tumor response to induction chemotherapy in children and young adults with lymphoma or sarcoma

Whole-Body DW MRI Can Help Assess Pediatric Tumor Response

0
Good agreement for treatment response assessments with DW MRI, FDG PET seen in children, young adults
Genomic targeted prostate cancer treatment shows a survival benefit in patients with metastatic castration-resistant prostate cancer

Genomically Targeted Treatment Slows Advanced Prostate Cancer

0
Men receiving olaparib versus standard treatment experience delayed disease progression

American Association for Cancer Research, April 27-28

0
The American Association for Cancer Research Annual Meeting 2020 The annual meeting of the American Association for Cancer Research was held virtually this...
Patients with cancer seem to be more vulnerable to COVID-19 and have higher risks for severe outcomes

Patients With Cancer Seem More Vulnerable to COVID-19

0
Frequency of severe events highest for patients with hematologic cancer, lung cancer, and metastatic cancer
The impact of COVID-19 on oncology clinical trials and long-term implications are discussed in a study and recommendations published in JCO Oncology Practice.

Impact of COVID-19 on Oncology Clinical Trials Discussed

0
Recommendations for sustaining cancer care access include permanent expanded support for telehealth

April 2020 Briefing – Hematology & Oncology

0
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for April 2020. This roundup includes...
Cancer patients have an increased case fatality rate from COVID-19

COVID-19 Case Fatality Rate Increased for Cancer Patients

0
Case fatality rates were 37 and 25 percent for hematologic and solid malignancies, respectively
Total insurance coverage

Medicaid Expansion Tied to Higher Mammography Rates

0
Expansion states saw higher Medicaid, total insurance coverage, and use of coverage for mammography